Catalyst Wire Dossier Catalyst Wire Dossier

CS1008 (investigational)

CS1008 · Daiichi Sankyo
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CS1008 (investigational), covering 2021-04-08 to 2021-04-08. Get the full timeline:

Most recent: Clinical Trial Update: CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer [Phase 2]

See pricing